Revelation Biosciences, Inc. Unit
REVBU
REVBU was delisted on the 11th of January, 2023.
4 hedge funds and large institutions have $59.9K invested in Revelation Biosciences, Inc. Unit in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
20% less funds holding
Funds holding: 5 → 4 (-1)
40% less capital invested
Capital invested by funds: $100K → $59.9K (-$40.1K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$5.33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$5K |
| 2 |
VF
Virtu Financial
New York
|
-$4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$757 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Walleye Capital
New York
| $35.5K | – | – | – |
|
2
Walleye Trading
New York
| $20.8K | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $3.46K | +$5.33K | +17,315 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $189 | -$757 | -2,462 | -76% |
|
|
TSS
5
Two Sigma Securities
New York
| – | -$5K | -15,215 | Closed |
|
|
VF
6
Virtu Financial
New York
| – | -$4K | -11,023 | Closed |
|
REVBU Hedge Fund Activity: Q4 2022 in Review
4 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences, Inc. Unit (REVBU) for Q4 2022, worth a combined $59.9K — down 40% from $100K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of REVBU and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $5.33K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $5K sold.
- 4 institutional investors held Revelation Biosciences, Inc. Unit (REVBU) as of Q4 2022, down from 5 in Q3 2022.
- Funds reported $59.9K of Revelation Biosciences, Inc. Unit stock for Q4 2022, down 40% quarter-over-quarter.
- 1 fund opened new Revelation Biosciences, Inc. Unit positions in Q4 2022 and 2 closed out, a net change of -1 holder.
- The largest Revelation Biosciences, Inc. Unit buyer in Q4 2022 was Citadel Advisors, an estimated $5.33K added.
- The largest Revelation Biosciences, Inc. Unit seller in Q4 2022 was Two Sigma Securities, an estimated $5K sold.
Based on aggregated 13F filings for Q4 2022.